ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate Resolution Includes $15 Billion For NIH In FY99

April 10, 1998

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002

In Brief: Grand Jury To Consider Charges Against N.M. Community Based Cancer Program Staff Members

January 4, 1980

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

November 26, 1999

As Shutdown Nears, House Republicans Press For Deeper Cuts and Repeal of Obamacare

September 13, 2013

Cancer Program Advocate Mary Lasker, 93, Prodded Government, Scientists For Cures

March 4, 1994